Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,998,274
-
Share change
-
+1,213,119
-
Total reported value
-
$8,732,732
-
Put/Call ratio
-
9.6%
-
Price per share
-
$0.58
-
Number of holders
-
73
-
Value change
-
+$776,751
-
Number of buys
-
20
-
Number of sells
-
20
Institutional Holders of AMPIO PHARMACEUTICALS INC - COM (AMPE) as of Q4 2019
As of 31 Dec 2019,
AMPIO PHARMACEUTICALS INC - COM (AMPE) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,998,274 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, CVA Family Office, LLC, GEODE CAPITAL MANAGEMENT, LLC, PRIVATE CAPITAL MANAGEMENT LLC, CVI Holdings, LLC, Valeo Financial Advisors, LLC, COURIER CAPITAL LLC, and Cypress Capital Management LLC (WY).
This page lists
73
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.